SMEDS A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  6.1% 6.1% 6.1% 6.1% 6.1%  
Bankruptcy risk  1.6% 4.4% 3.5% 1.2% 1.2%  
Credit score (0-100)  76 47 52 82 80  
Credit rating  A BBB BBB A A  
Credit limit (kDKK)  5.0 0.0 0.0 76.0 80.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Gross profit  1,017 504 476 973 922  
EBITDA  340 -64.4 3.1 545 630  
EBIT  223 -172 -67.3 544 630  
Pre-tax profit (PTP)  184.1 -189.5 -104.5 520.3 635.8  
Net earnings  146.6 -152.9 -83.9 408.6 493.7  
Pre-tax profit without non-rec. items  184 -190 -104 520 636  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  1,884 1,844 1,926 1,695 1,695  
Shareholders equity total  2,151 1,888 1,691 1,985 2,361  
Interest-bearing liabilities  12.7 28.4 204 131 92.7  
Balance sheet total (assets)  3,179 2,927 2,905 3,290 3,508  

Net Debt  -902 -741 -278 -1,184 -1,178  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,017 504 476 973 922  
Gross profit growth  21.8% -50.4% -5.5% 104.2% -5.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,179 2,927 2,905 3,290 3,508  
Balance sheet change%  -5.2% -7.9% -0.7% 13.2% 6.6%  
Added value  340.0 -64.4 3.1 614.0 630.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -435 -147 11 -232 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 -2.0 1.0 2.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  21.9% -34.1% -14.1% 55.9% 68.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  6.3% -5.4% -2.3% 17.7% 19.4%  
ROI %  9.6% -8.1% -3.6% 27.3% 28.7%  
ROE %  6.9% -7.6% -4.7% 22.2% 22.7%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  67.7% 64.5% 58.2% 60.3% 67.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -265.3% 1,150.8% -9,053.0% -217.3% -186.9%  
Gearing %  0.6% 1.5% 12.0% 6.6% 3.9%  
Net interest  0 0 0 0 0  
Financing costs %  187.9% 117.4% 31.0% 17.5% 21.6%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  1.2 1.0 0.9 1.3 1.6  
Current Ratio  1.3 1.0 0.9 1.3 1.7  
Cash and cash equivalent  915.0 769.4 481.6 1,314.9 1,270.8  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  214.8 -23.9 -179.0 320.1 642.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  340 -64 3 614 630  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  340 -64 3 545 630  
EBIT / employee  223 -172 -67 544 630  
Net earnings / employee  147 -153 -84 409 494